Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wallingford
Wallingford, Connecticut, United Stateswallingfordct.gov ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Bio-Techne’s Wallingford facility manufactures cartridges for the Ella Automated Immunoassay System, enabling rapid and highly reproducible multiplex biomarker detection. The platform supports over 200 analytes and is used globally in life science research and clinical applications. The new facility expansion increases cartridge production capacity to 500,000 per year to meet growing demand[2][3].
- Therapeutic areas
- OtherOncologyImmunologyNeurology
- Modalities
- ImmunoassayDiagnostic deviceMicrofluidics
- Industry
- Protein Biomarker Diagnostics
Beyond the preview
Go deeper on Wallingford.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wallingford.